{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:06:06Z","timestamp":1788894366186,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11912-021-01115-w","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T16:03:20Z","timestamp":1630080200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women\u2019s Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-3520","authenticated-orcid":false,"given":"Na Tosha N.","family":"Gatson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerianne R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jada K. O.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekokobe","family":"Fonkem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"issue":"8","key":"1115_CR1","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00520-019-05228-8","volume":"28","author":"M Salakari","year":"2020","unstructured":"Salakari M, Nurminen R, Sillanm\u00e4ki L, Pylkk\u00e4nen L, Suominen S. The importance of and satisfaction with sex life among breast cancer survivors in comparison with healthy female controls and women with mental depression or arterial hypertension: results from the Finnish nationwide HeSSup cohort study. Support Care Cancer. 2020;28(8):3847\u201354.","journal-title":"Support Care Cancer"},{"issue":"5","key":"1115_CR2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/pon.5047","volume":"28","author":"C von Hippel","year":"2019","unstructured":"von Hippel C, Rosenberg SM, Austin SB, Sprunck-Harrild K, Ruddy KJ, Schapira L, et al. Identifying distinct trajectories of change in young breast cancer survivors\u2019 sexual functioning. Psychooncology. 2019;28(5):1033\u201340.","journal-title":"Psychooncology"},{"issue":"3","key":"1115_CR3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jsxm.2016.11.324","volume":"14","author":"A Salonia","year":"2017","unstructured":"Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, et al. Sexual rehabilitation after treatment for prostate cancer-part 2: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017;14(3):297\u2013315.","journal-title":"J Sex Med"},{"issue":"3","key":"1115_CR4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.sxmr.2020.01.004","volume":"8","author":"MK McInnis","year":"2020","unstructured":"McInnis MK, Pukall CF. Sex after prostate cancer in gay and bisexual men: a review of the literature. Sex Med Rev. 2020;8(3):466\u201372.","journal-title":"Sex Med Rev"},{"issue":"1","key":"1115_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/aja.aja_18_17","volume":"20","author":"WJ Zhou","year":"2018","unstructured":"Zhou WJ, Ma SC, Zhao M, Liu C, Guan XD, Bao ZS, et al. Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis. Asian J Androl. 2018;20(1):43\u20139.","journal-title":"Asian J Androl"},{"issue":"6","key":"1115_CR6","first-page":"503","volume":"37","author":"PM Bouloux","year":"1987","unstructured":"Bouloux PM, Grossman A. Hyperprolactinaemia and sexual function in the male. Br J Hosp Med. 1987;37(6):503\u201310.","journal-title":"Br J Hosp Med"},{"issue":"5","key":"1115_CR7","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1743-6109.2008.01206.x","volume":"6","author":"G Corona","year":"2009","unstructured":"Corona G, Mannucci E, Jannini EA, Lotti F, Ricca V, Monami M, et al. Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction. J Sex Med. 2009;6(5):1457\u201366.","journal-title":"J Sex Med"},{"issue":"1","key":"1115_CR8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/pon.4463","volume":"27","author":"KA Donovan","year":"2018","unstructured":"Donovan KA, Gonzalez BD, Nelson AM, Fishman MN, Zachariah B, Jacobsen PB. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: a controlled comparison. Psychooncology. 2018;27(1):316\u201324.","journal-title":"Psychooncology"},{"issue":"2","key":"1115_CR9","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1097\/01.NCC.0000305695.12873.d5","volume":"31","author":"A Hordern","year":"2008","unstructured":"Hordern A. Intimacy and sexuality after cancer: a critical review of the literature. Cancer Nurs. 2008;31(2):E9\u201317. https:\/\/doi.org\/10.1097\/01.NCC.0000305695.12873.d5.","journal-title":"Cancer Nurs"},{"issue":"Supplement_1","key":"1115_CR10","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"\u2022\u2022Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro Oncol. 2020;22(Supplement_1):iv1\u201396. https:\/\/doi.org\/10.1093\/neuonc\/noaa200The CBTRUS is a premiere epidemiological resource for use in brain tumor. This most recent issue also includes information about brain tumor statistics in rural populations.","journal-title":"Neuro Oncol"},{"issue":"10","key":"1115_CR11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/dji132","volume":"97","author":"R Kaaks","year":"2005","unstructured":"Kaaks R, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2005;97(10):755\u201365.","journal-title":"J Natl Cancer Inst"},{"key":"1115_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2018.09.001","volume":"438","author":"D Zheng","year":"2018","unstructured":"Zheng D, Williams C, Vold JA, et al. Regulation of sex hormone receptors in sexual dimorphism of human cancers. Cancer Lett. 2018;438:24\u201331.","journal-title":"Cancer Lett"},{"issue":"18","key":"1115_CR13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1200\/JCO.2014.59.1602","volume":"33","author":"LA Brinton","year":"2015","unstructured":"Brinton LA, Key TJ, Kolonel LN, et al. Prediagnostic sex steroid hormones in relation to male breast cancer risk. J Clin Oncol. 2015;33(18):2041\u201350.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1115_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/neuonc\/now092","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united states in 2009\u20132013. Neuro Oncol. 2016;18(5):1\u201375.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1115_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-006-9146-9","volume":"80","author":"K Korhonen","year":"2006","unstructured":"Korhonen K, et al. Female predominance in meningiomas cannot be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol. 2006;80(1):1\u20137.","journal-title":"J Neurooncol"},{"issue":"4","key":"1115_CR16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10143-004-0340-y","volume":"27","author":"S Wolfsberger","year":"2004","unstructured":"Wolfsberger S, et al. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature. Neurosurg Rev. 2004;27(4):238\u201345.","journal-title":"Neurosurg Rev"},{"issue":"34","key":"1115_CR17","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1200\/JCO.2015.61.6490","volume":"33","author":"Y Ji","year":"2015","unstructured":"Ji Y, Rankin C, Grunberg S, Sherrod AE, Ahmadi J, Townsend JJ, et al. Double-blind phase III randomized trial of the antiprogestin agent mifepristone in the treatment of unresectable meningioma: SWOG S9005. J Clin Oncol. 2015;33(34):4093\u20138.","journal-title":"J Clin Oncol"},{"key":"1115_CR18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3171\/jns.1994.81.2.0184","volume":"81","author":"AB Rubinstein","year":"1994","unstructured":"Rubinstein AB, Loren D, Geier A, Reichenthal E, Gadoth N. Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg. 1994;81:184\u20137.","journal-title":"J Neurosurg"},{"issue":"10","key":"1115_CR19","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1586\/ern.11.38","volume":"11","author":"MC Chamberlain","year":"2014","unstructured":"Chamberlain MC, Barnholtz JS. Medical treatment of recurrent meningiomas. Exp Rev Neurothera. 2014;11(10):1425\u201332.","journal-title":"Exp Rev Neurothera"},{"key":"1115_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3171\/jns.1995.82.3.0453","volume":"82","author":"RS Carroll","year":"1995","unstructured":"Carroll RS, Zhang J, Dashner K, Sar M, Wilson EM, Black PM. Androgen receptor expression in meningiomas. J Neurosurg. 1995;82:453\u201360.","journal-title":"J Neurosurg"},{"issue":"12","key":"1115_CR21","doi-asserted-by":"crossref","first-page":"e83261","DOI":"10.1371\/journal.pone.0083261","volume":"8","author":"Z Qi","year":"2013","unstructured":"Qi Z, Shao C, Huang Y, Huo G, Zhou Y, Wang Z. Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS ONE. 2013;8(12):e83261.","journal-title":"PLoS ONE"},{"issue":"2","key":"1115_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2007.14.2133","volume":"26","author":"S Blitshteyn","year":"2008","unstructured":"Blitshteyn S, Cook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol. 2008;26(2):279\u201382.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1115_CR23","first-page":"e147","volume":"15","author":"X Shu","year":"2019","unstructured":"\u2022\u2022Shu X, et al. Association of hormone replacement therapy with increased risk of meningioma in women: A hospital-based multicenter study with propensity score matching. Asia Pac J Clin Oncol. 2019;15(5):e147\u201353 This paper deals with an actual patient population and is valuable to the clinical practitioners in this way. This is also important to help drive guideline development for this very common intracranial tumor in women.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"1115_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12253-018-00569-x","volume":"26","author":"T Deli","year":"2020","unstructured":"Deli T, et al. Hormone replacement therapy in cancer survivors - review of the literature. Pathol Oncol Res. 2020;26(1):63\u201378.","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"1115_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ogc.2018.01.009","volume":"45","author":"A Mccormick","year":"2018","unstructured":"Mccormick A, Peterson E. Cancer in pregnancy. Obstet Gynecol Clin North Am. 2018;45(2):187\u2013200.","journal-title":"Obstet Gynecol Clin North Am."},{"issue":"9","key":"1115_CR26","first-page":"1289","volume":"16","author":"S Yust-Katz","year":"2014","unstructured":"Yust-Katz S, de Groot JF, Liu D, Wu J, Yuan Y, Anderson MD, et al. Pregnancy and glial brain tumors. Neurooncology. 2014;16(9):1289\u201394.","journal-title":"Neurooncology"},{"issue":"1","key":"1115_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-018-2851-3","volume":"139","author":"A van Westrhenen","year":"2018","unstructured":"van Westrhenen A, Senders JT, Martin E, DiRisio AC, Broekman MLD. Clinical challenges of glioma and pregnancy: a systematic review. J Neurooncol. 2018;139(1):1\u201311.","journal-title":"J Neurooncol"},{"key":"1115_CR28","first-page":"1","volume":"128","author":"S Peeters","year":"2017","unstructured":"Peeters S, Pag\u00e8s M, Gauchotte G, et al. Interactions between glioma and pregnancy: insight from a 52-case multicenter series. J Neurosurg. 2017;128:1\u201311.","journal-title":"J Neurosurg"},{"issue":"12","key":"1115_CR29","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1007\/s00415-009-5232-1","volume":"256","author":"J Pallud","year":"2009","unstructured":"Pallud J, Duffau H, Razak RA, et al. Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group. J Neurol. 2009;256(12):2014\u201320.","journal-title":"J Neurol"},{"issue":"3","key":"1115_CR30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ana.21888","volume":"67","author":"J Pallud","year":"2010","unstructured":"Pallud J, Mandonnet E, Deroulers C, et al. Pregnancy increases the growth rates of World Health Organization Grade II Gliomas. Ann Neurol. 2010;67(3):398\u2013404.","journal-title":"Ann Neurol"},{"issue":"3","key":"1115_CR31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ecl.2019.05.004","volume":"48","author":"W Huang","year":"2019","unstructured":"Huang W, Molitch ME. Pituitary tumors in pregnancy. Endocrinol Metab Clin North Am. 2019;48(3):569\u201381.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"1115_CR32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317(5):516\u201324.","journal-title":"JAMA"},{"issue":"1","key":"1115_CR33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11102-019-01010-5","volume":"23","author":"A Glezer","year":"2020","unstructured":"\u2022\u2022Glezer A, Bronstein MD. Prolactinomas in pregnancy: considerations before conception and during pregnancy. Pituitary. 2020;23(1):65\u20139 This is an important read as this offers up-to-date information for the clinical providers about considerations in the treatment and surveillance of these patients. This paper covers a very common hormone-dependent intracranial tumor which commonly impact reproductive and sexuality in women.","journal-title":"Pituitary"},{"issue":"3","key":"1115_CR34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13304-017-0424-1","volume":"69","author":"Z Anastasiadi","year":"2017","unstructured":"Anastasiadi Z, et al. Breast cancer in young women: an overview. Updates Surg. 2017;69(3):313\u20137.","journal-title":"Updates Surg"},{"issue":"4","key":"1115_CR35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/humupd\/dmh025","volume":"10","author":"ESHRE Capri Workshop Group","year":"2004","unstructured":"ESHRE Capri Workshop Group. Hormones and breast cancer. Hum Reprod Update. 2004;10(4):281\u201393.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1115_CR36","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","volume":"8","author":"H Yao","year":"2017","unstructured":"Yao H, et al. Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget. 2017;8(1):1913\u201324.","journal-title":"Oncotarget"},{"issue":"5","key":"1115_CR37","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","volume":"8","author":"S Al-Mahmood","year":"2018","unstructured":"Al-Mahmood S, et al. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res. 2018;8(5):1483\u2013507.","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"1115_CR38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jnci\/djr030","volume":"103","author":"AI Phipps","year":"2011","unstructured":"Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst. 2011;103(6):470.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1115_CR39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-019-05317-6","volume":"177","author":"NB Figura","year":"2019","unstructured":"Figura NB, et al. Breast leptomeningeal disease: a review of current practices and updates on management. Breast Cancer Res Treatment. 2019;177(2):277\u201394.","journal-title":"Breast Cancer Res Treatment"},{"issue":"suppl_6","key":"1115_CR40","first-page":"vi283","volume":"20","author":"NT Gatson","year":"2018","unstructured":"\u2022Gatson NT. CADD-53. Glioblastoma tumorgenesis \u2013 lessons from reproductive immunology. Neurooncology. 2018;20(suppl_6):vi283 This work discusses the biological and immunological overlap between fetal development and glioma development. This is important to provide an overview of the potential research future directions as well as helping with understanding of tumor progression during pregnancy.","journal-title":"Neurooncology"},{"issue":"suppl_6","key":"1115_CR41","first-page":"vi193","volume":"18","author":"NN Gatson","year":"2016","unstructured":"Gatson NN, Pillianayagam C, Rao G, Chi TL, Prabhu S, Weathers S. SURG-12. Laser interstitial thermal therapy (LITT) to manage progressed glioblastoma during pregnancy. Neurooncology. 2016;18(suppl_6):vi193.","journal-title":"Neurooncology"},{"issue":"44","key":"1115_CR42","doi-asserted-by":"crossref","first-page":"71330","DOI":"10.18632\/oncotarget.11114","volume":"7","author":"F Gao","year":"2016","unstructured":"Gao F, Cui Y, Jiang H, Dali S, Wang Y, Jiang Z, et al. Circulating tumor cell is a common property of brain glioma and promotes the monitoring system. Oncotarget. 2016;7(44):71330\u201340.","journal-title":"Oncotarget"},{"issue":"1","key":"1115_CR43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jama.292.1.75","volume":"292","author":"K Khosrotehrani","year":"2004","unstructured":"Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004;292(1):75\u201380.","journal-title":"JAMA"},{"issue":"9","key":"1115_CR44","doi-asserted-by":"crossref","first-page":"e45592","DOI":"10.1371\/journal.pone.0045592","volume":"7","author":"WN Chan","year":"2012","unstructured":"Chan WN, Gurnot C, Montine TJ, Sonnen JA, Guthrie KA, Nelson JL. Male microchimerism in the human female brain. PLoS ONE. 2012;7(9):e45592.","journal-title":"PLoS ONE"},{"issue":"8","key":"1115_CR45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.COT.0000312819.01966.79","volume":"23","author":"RH Carlson","year":"2001","unstructured":"\u2022\u2022Carlson RH. Study: women with brain tumors have 10 times rate of divorce as men with brain tumors. Oncol Times. 2001;23(8):63 While this paper was published 20 years ago, it remains the most reliable study that evaluates the social and psychological impact of brain tumors as it pertains to women. This further emphasizes the fact that little research has been focused on this issue in the neuro-oncology of women.","journal-title":"Oncol Times"},{"issue":"4","key":"1115_CR46","first-page":"183","volume":"18","author":"KD Heinrichs","year":"2009","unstructured":"Heinrichs KD, MacKnee C, Auton-Cuff F, Domene JF. Factors affecting sexual-self esteem among young adult women in long-term heterosexual relationships. Can J Hum Sex. 2009;18(4):183\u201399.","journal-title":"Can J Hum Sex"},{"issue":"2","key":"1115_CR47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bodyim.2009.01.001","volume":"6","author":"RM Calogero","year":"2009","unstructured":"Calogero RM, Thompson JK. Potential implications of the objectification of women\u2019s bodies for women\u2019s sexual satisfaction. Body Image. 2009;6(2):145\u20138.","journal-title":"Body Image"},{"issue":"1","key":"1115_CR48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3171\/2017.2.JNS161659","volume":"129","author":"S Bragstad","year":"2018","unstructured":"\u2022Bragstad S, Flatebo M, Natvig GK, Eide GE, Skeie GO, Behbahani M, et al. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. J Neurosurg. 2018;129(1):71\u201383 Comparative study in lung cancer of the importance of quality of life on survival.","journal-title":"J Neurosurg"},{"issue":"3","key":"1115_CR49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-005-7020-9","volume":"76","author":"PD Brown","year":"2006","unstructured":"Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76(3):283\u201391.","journal-title":"J Neurooncol"},{"issue":"3","key":"1115_CR50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/13548506.2016.1210176","volume":"22","author":"CY Finocchiaro","year":"2017","unstructured":"Finocchiaro CY, et al. Hidden reality: sexual sphere in brain tumor patients. Psychol Health Med. 2017;22(3):370\u201380.","journal-title":"Psychol Health Med"},{"issue":"4","key":"1115_CR51","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/neuonc\/nou326","volume":"17","author":"W Surbeck","year":"2015","unstructured":"Surbeck W, Herbet G, Duffau H. Sexuality after surgery for diffuse low-grade glioma. Neuro Oncol. 2015;17(4):574\u20139.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1115_CR52","first-page":"81","volume":"98","author":"PO Lundberg","year":"1991","unstructured":"Lundberg PO, Hulter B. Sexual dysfunction in patients with hypothalamo-pituitary disorders. Exp Clin Endocrinol. 1991;98(2):81\u20138.","journal-title":"Exp Clin Endocrinol"},{"key":"1115_CR53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.wneu.2016.09.066","volume":"97","author":"HA Zaidi","year":"2017","unstructured":"Zaidi HA, Cote DJ, Castlen JP, Burke WT, Liu YH, Smith TR, et al. Time course of resolution of hyperprolactinemia after transsphenoidal surgery among patients presenting with pituitary stalk compression. World Neurosurg. 2017;97:2\u20137.","journal-title":"World Neurosurg"},{"issue":"4","key":"1115_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1517\/14740338.2016.1151493","volume":"15","author":"RS Auriemma","year":"2016","unstructured":"Auriemma RS, Grasso LF, Pivonello R, Colao A. The safety of treatments for prolactinomas. Expert Opin Drug Saf. 2016;15(4):503\u201312. https:\/\/doi.org\/10.1517\/14740338.2016.1151493.","journal-title":"Expert Opin Drug Saf"},{"key":"1115_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000207607","volume":"15","author":"KH Darzy","year":"2009","unstructured":"Darzy KH, Shalet SM. Hypopituitarism following radiotherapy revisited. Endocrine Dev. 2009;15:1\u201324.","journal-title":"Endocrine Dev"},{"issue":"5 Suppl","key":"1115_CR56","first-page":"78","volume":"28","author":"KH Darzy","year":"2005","unstructured":"Darzy KH, Shalet SM. Hypopituitarism after cranial irradiation. J Endocrinol Invest. 2005;28(5 Suppl):78\u201387.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1115_CR57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/cen.12550","volume":"82","author":"E Ritvonen","year":"2015","unstructured":"Ritvonen E, Karppinen A, Sintonen H, Vehkavaara S, Kivipelto L, Roine RP, et al. Normal long-term health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment. Clin Endocrinol (Oxf). 2015;82(3):412\u201321.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1115_CR58","first-page":"65","volume":"45","author":"S Acquati","year":"2001","unstructured":"Acquati S, Pizzocaro A, Tomei G, Giovanelli M, Libe R, Faglia G, et al. A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma. J Neurosurg Sci. 2001;45(2):65\u20139.","journal-title":"J Neurosurg Sci"},{"key":"1115_CR59","first-page":"187","volume":"4","author":"C Lucchiari","year":"2010","unstructured":"Lucchiari C, Botturi A, Pravettoni G. The impact of decision models on self-perceived quality of life: a study on brain cancer patients. Ecancermedicalscience. 2010;4:187.","journal-title":"Ecancermedicalscience"},{"issue":"5","key":"1115_CR60","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40271-020-00434-7","volume":"13","author":"Y Sugitani","year":"2020","unstructured":"Sugitani Y, Sugitani N, Ono S. Quantitative preferences for lung cancer treatment\u00a0from the\u00a0patients\u2019 perspective: a systematic review. Patient. 2020;13(5):521\u201336. https:\/\/doi.org\/10.1007\/s40271-020-00434-7.","journal-title":"Patient"},{"issue":"9","key":"1115_CR61","first-page":"3053","volume":"85","author":"JJ Pinzone","year":"2000","unstructured":"Pinzone JJ, Katznelson L, Danila DC, Pauler DK, Miller CS, Klibanski A. Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab. 2000;85(9):3053\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"1115_CR62","doi-asserted-by":"crossref","unstructured":"\u2022\u2022Boccia ML, Anyanda EI, Fonkem E. A preliminary report on quality of life and sexual function in brain tumor patients. J Sex Med. 2021;18(4):737\u201342. Detailed study of impact of brain tumor diagnosis and treatment on sexual function and relationship of sexual function to quality of life in these patients.","DOI":"10.1016\/j.jsxm.2021.01.171"},{"issue":"S2","key":"1115_CR63","first-page":"ii179","volume":"22","author":"M Boccia","year":"2020","unstructured":"Boccia M, Anyanda EI, Fonkem E. A preliminary report on quality of life and sexual function in brain cancer patients. Neurooncology. 2020;22(S2):ii179.","journal-title":"Neurooncology"},{"issue":"1","key":"1115_CR64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1743-6109.2012.02987.x","volume":"10","author":"AW Shindel","year":"2013","unstructured":"Shindel AW, Parish SJ. Sexuality education in North American medical schools current status and future directions. J Sex Med. 2013;10(1):3\u201317 quiz 8.","journal-title":"J Sex Med"},{"issue":"6","key":"1115_CR65","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1530\/eje.1.02030","volume":"153","author":"G Minniti","year":"2005","unstructured":"Minniti G, Esposito V, Piccirilli M, Fratticci A, Santoro A, Jaffrain-Rea ML. Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol. 2005;153(6):723\u201335.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1115_CR66","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/jwh.2018.7516","volume":"28","author":"JA Simon","year":"2019","unstructured":"Simon JA, Thorp J, Millheiser L. Flibanserin for premenopausal hypoactive sexual desire disorder: pooled analysis of clinical trials. J Womens Health. 2019;28(6):769\u201377.","journal-title":"J Womens Health"},{"issue":"7","key":"1115_CR67","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1060028019899152","volume":"54","author":"D Mayer","year":"2020","unstructured":"\u2022\u2022Mayer D, Lynch SE. Bremelanotide: new drug approved for treating hypoactive sexual desire disorder. Ann Pharmacother. 2020;54(7):684\u201390 Important new option for treatment of hypoactive sexual desire disorder in women that may be useful for treating patients with this diagnosis.","journal-title":"Ann Pharmacother"},{"key":"1115_CR68","unstructured":"Institute of Medicine (US) Committee on the ethical and legal issues relating to the inclusion of women in clinical studies. In: Mastroianni AC, Faden R, Federman D editors. Women and health research: ethical and legal issues of including women in clinical studies: volume 2: workshop and commissioned papers. Washington (DC): National Academies Press (US); 1999. Women's participation in clinical research: from protectionism to access. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK236577. Accessed 20 Jan\u00a02021."}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-021-01115-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-021-01115-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-021-01115-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T23:04:11Z","timestamp":1699398251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-021-01115-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1007\/s11912-021-01115-w","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,27]]},"assertion":[{"value":"22 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Na Tosha N. Gatson has served as an advisory board consultant for Novocure. Maria L. Boccia declares that she has no conflict of interest. Kerianne R. Taylor declares that she has no conflict of interest. Jada K.O. Mack declares that she has no conflict of interest. Ekokobe Fonkem has served as an advisory board consultant for Novocure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards as per the institutional and international research committee standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}],"article-number":"127"}}